STESs, Smt. K. N. College of Pharmacy, S. P. Pune University, Pune, Maharashtra, India.
Indian J Pharmacol. 2020 Jul-Aug;52(4):306-312. doi: 10.4103/ijp.IJP_609_19.
The aim of this study is to evaluate silk-fibroin electrospun nanofibers and blood-derived fibroblast-like cells for cytotoxicity and cell adhesion.
Silk fibroin (SF) has emerged as a favorable and potential bio-material owing to its unique properties such as biocompatibility, biodegradability, the possibility of functional modifications, mechanical strength, and regenerative capability. Despite current advancements in tissue engineering technologies, delay wound healing and scar formation remain unresolved. Bioequivalent skin graft having human fibroblast and keratinocytes (Apligraft) has proven to be beneficial, but the cost is a limiting factor.
The blood born fibroblast-like cells express several growth factors, extracellular matrix proteins, and these factors are crucial in the various steps of the wound-healing process. SF is an idea polymer by the virtue of its multifaceted characteristics such as mechanical strength, biodegradability, improved cell attachment, biocompatibility, good elasticity, having application in biomedical, tissue engineering, and medicine. The objective of the present study is to evaluate SF as a biomaterial for making nanofibers scaffold and culturing blood-derived fibroblast-like cells on it for the potential application to wound site.
Blood-derived fibroblast-like cells evaluated for cytotoxicity, collagen 1 expression, and cell adhesion on SF electrospun nanofibers. The silk nanofibers were fabricated by the electrospinning method using silk-derived fibroin solution and analyzed for protein composition, viscosity, and further characterized using the Fourier transformed infrared spectroscopy.
The SF nanofibers were nontoxic to the blood-derived fibroblast-like cells. It improved cell adhesion with collagen 1 expression.
The composite scaffold of SF nanofibers with blood-derived fibroblast-like cells would be a potential healing patch for many types of wounds.
本研究旨在评估丝素蛋白电纺纳米纤维和血液来源的成纤维细胞样细胞的细胞毒性和细胞黏附性。
丝素蛋白(SF)由于其独特的性能,如生物相容性、可生物降解性、功能修饰的可能性、机械强度和再生能力,已成为一种有前途的生物材料。尽管组织工程技术取得了目前的进展,但延迟伤口愈合和瘢痕形成仍然是一个未解决的问题。具有人成纤维细胞和角质形成细胞的生物等效皮肤移植物(Apligraft)已被证明是有益的,但成本是一个限制因素。
血液来源的成纤维细胞样细胞表达多种生长因子、细胞外基质蛋白,这些因子在伤口愈合过程的各个步骤中都很重要。SF 是一种理想的聚合物,具有多方面的特性,如机械强度、可生物降解性、改善细胞附着、生物相容性、良好的弹性,在生物医学、组织工程和医学中有应用。本研究的目的是评估 SF 作为制造纳米纤维支架的生物材料,并在其上培养血液来源的成纤维细胞样细胞,以潜在地应用于伤口部位。
评估血液来源的成纤维细胞样细胞的细胞毒性、胶原蛋白 1 表达和在 SF 电纺纳米纤维上的细胞黏附性。通过使用丝素衍生的纤维蛋白溶液的电纺方法制造丝纳米纤维,并分析其蛋白质组成、粘度,并进一步使用傅里叶变换红外光谱进行表征。
SF 纳米纤维对血液来源的成纤维细胞样细胞无毒。它改善了细胞黏附,并促进了胶原蛋白 1 的表达。
SF 纳米纤维与血液来源的成纤维细胞样细胞的复合支架将是许多类型伤口的潜在愈合贴片。